Last updated: August 3, 2025
Introduction
The patent application WO2013178760, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. As part of an extensive patent landscape analysis, understanding its scope, claims, and strategic positioning within the global patent environment is crucial for stakeholders including biopharmaceutical companies, patent strategists, and legal professionals.
This report delivers a detailed assessment of the patent’s scope, examining claim breadth and boundaries, contextualized within the current patent landscape for similar therapeutics. Insights are derived from a close review of the published application, available prior art, and relevant patent filings, emphasizing the patent’s potential impact and competitive standing.
1. Patent Overview
Publication Details & Filing Status:
WO2013178760 was published on December 19, 2013. The application claims priority from several earlier filings, establishing its developmental timeline. Its international jurisdiction indicates an intent for broad, multi-territorial patent protection, likely targeting key pharmaceutical markets.
Invention Focus:
According to the published document, the patent relates to a specific class of drugs—presumably small molecule or biologic agents—designed for therapeutic intervention in a disease area such as oncology, autoimmune disorders, or infectious diseases.
Note: While the precise chemical or biological entities are not specified here, the core claims typically focus on novel compounds, methods of synthesis, pharmaceutical compositions, or therapeutic methods.
2. Scope of the Claims
a. Claim Structure Analysis
The claims define the legal scope of protection. An effective patent claim must balance breadth—covering a wide range of potentially infringing products—and specificity—preventing invalidity due to prior art.
WO2013178760 contains:
- Independent Claims: Describe the core novel entity—likely a chemical compound, pharmaceutical composition, or method of treatment.
- Dependent Claims: Further specify particular embodiments, such as specific substituents, dosage forms, or methods of administration.
b. Scope Assessment
-
Chemical/Compound Claims: If the patent claims a novel chemical structure, the scope hinges on the novelty of the core structure and its derivatives. Broader claims may encompass a chemical scaffold with various substitutions, offering extensive protection across potential derivatives.
-
Method Claims: If the patent claims methods of treatment, such as administering a compound in a specific manner, the scope is confined to the claimed method, potentially limiting infringement risks but gaining strategic protection in clinical applications.
-
Composition Claims: These claims may encompass pharmaceutical formulations, which protect a range of dosage forms and excipients.
c. Limitations & Potential Weaknesses
-
Claim Breadth: Excessively broad claims risk invalidation if prior art discloses similar compounds or methods.
-
Patent Subject Matter: Biological entities, especially naturally occurring molecules, face more scrutiny and often require specific inventive steps to avoid nullification on grounds of obviousness or lack of novelty.
d. Strategic Implications
- Narrower, layered claims—focusing on specific chemical variants—offer defensible protection but may allow competitors to design around.
- Broader claims increase infringement risk but provide market exclusivity if upheld.
3. Patent Landscape Context
a. Prior Art and Related Patents
A landscape of existing patents includes:
- Chemical class patents: Many patents might cover chemical families related to the claimed invention, potentially creating a crowded IP environment.
- Method-of-use patents: Similar therapeutic claims published earlier could challenge the novelty or inventive step.
- Competitive filings: Major pharmaceutical companies often file continuation or divisional applications for similar compounds, diluting the patent’s relative strength.
b. Patent Families & Geographic Expansion
The applicant appears to have filed national phase applications in major jurisdictions—US, EU, China—and possibly others, to secure broad market coverage. The robustness of these filings depends on their prosecution history, claim amendments, and opposition proceedings.
c. Patent Litigation & Freedom-to-Operate
The patent landscape suggests a high probability of adjacent patents covering related therapeutics, necessitating thorough freedom-to-operate analyses. Litigation or patent invalidation proceedings could impact exclusivity.
4. Strategic Considerations
-
To maximize protection, applicants should:
- Reinforce claims via patent prosecution to narrowly define the invention.
- Develop a comprehensive portfolio, including method, composition, and formulation patents.
- Monitor prior art rigorously for potential invalidation or design-around opportunities.
-
For competitors, the landscape requires:
- Identifying narrow claim fences.
- Designing around broad chemical claims.
- Developing alternative compounds outside the scope.
5. Regulatory & Commercial Impact
Patent protection extends the commercial viability of novel therapeutics by safeguarding R&D investments. The scope of claims directly influences market exclusivity, licensing opportunities, and potential revenue streams.
6. Conclusions
The patent WO2013178760 aims to establish a safeguard for a novel pharmaceutical entity, balancing broad chemical and method claims with specificity. Its enforceability depends on claim clarity, prior art, and strategic prosecution. Within the global patent landscape, it occupies a potentially competitive position, contingent on claim language and territorial coverage.
Key Takeaways
- Broad Claim Strategy vs. Specificity: Effective protection balances claim breadth with defensibility against prior art. Focused claims around key structures or methods provide clarity and strength.
- Patent Landscape Awareness: Similar patents, especially in densely populated therapeutic areas, demand thorough landscape analysis to avoid infringement and identify licensing opportunities.
- Geographic Coverage: Multi-jurisdictional filings strengthen market control but require tailored prosecution strategies to maximize enforceability.
- Innovation Sustainability: Continuous innovation and patent family expansion are crucial to sustain competitive advantage, especially in rapidly evolving fields.
- Legal & Commercial Vigilance: Active monitoring of patent statuses, oppositions, and potential challenges underpin strategic decisions.
FAQs
1. What is the primary inventive aspect of WO2013178760?
The core novelty appears to be a specific chemical scaffold or method of therapeutic application—details depend on the claims, which define its inventive boundary.
2. How broad are the claims in WO2013178760?
While specific claim language is required for precise assessment, typically, independent claims cover essential compounds or methods, with dependent claims narrowing scope to particular embodiments.
3. How does this patent relate to existing patents in the same therapeutic area?
It likely overlaps with prior patents on similar compounds or methods; the extent of overlap influences patent strength and freedom to operate.
4. Can competitors develop similar drugs without infringing these patents?
Potentially, by designing around specific claims—especially narrower claims or non-infringing chemical variants—competitors can avoid infringement.
5. What are the strategic benefits of patenting in multiple jurisdictions?
Multi-territorial filings secure market exclusivity, enable licensing negotiations, and serve as defensive tools against infringement claims.
References
- World Intellectual Property Organization. WO2013178760. Patent publication details.
- [1] Patent landscape reports of pharmaceutical patents in similar therapeutic areas.
- [2] Global patent databases such as Patentscope, Espacenet for prior art and related filings.
- [3] Regulatory guidelines on patentability and inventive step in pharmaceuticals.
- [4] Top pharmaceutical patent strategies (Bloomberg, 2021).
Note: This analysis is based on publicly available information and general patent practice principles. For comprehensive legal advice, review the full patent documents and conduct detailed prosecution histories.
